The concept in brief — Light into the darkness: Model-based Pulse Wave Analysis (mbPWA)
Protecting heart and arteries more effectively than ever before
The concept in brief
Light into the Dark: Model-based Pulse Wave Analysis (mbPWA)
We have invented a measurement method based on artificial intelligence that looks at cardiovascular health from an entirely new angle.
Far superior to conventional measurement methods, our approach excels in ultrahigh precision of the values determined, combined with outstanding usability and patient benefit.
Measure heart and arteries — detect risks earlier
Early and, ideally, regular monitoring based on reliable measurement data is essential to protect the heart and arteries and maintain cardiovascular functionality for as long as possible.
Valid, science-based statements about the individual heart and vascular condition are essential to identify cardiovascular disease risks (heart failure, cardiac infarction, etc.) or peripheral circulatory disorders (e.g., peripheral arterial disease, PAD).
Where conventional measurement methods fail
The handicap of all current measurement techniques lies in the circuitous determination of cardiovascular data via surrogate parameters such as Augmentation Index (AIx), Pulse Wave Velocity (PWV), or Flow Mediated Dilation (FMD).
Cardiovascular data, thus obtained only indirectly via analytical ‘dissection’ of features of the pulse waveform, shows unsatisfactorily low precision. Therefore, the measurement results lack both validity and plausibility. Even worse, limitations in arterial dilatability are reported significantly too late due to low sensitivity.
Measuring directly instead of indirectly
Problem solved: Our solution is Model-based Pulse Wave Analysis (mbPWA). Specially designed measurement algorithms are at the heart of this revolutionary novel measurement method. Thus, it is possible to determine the wall stiffness and flow resistance of the arteries within a few minutes. Besides, for the first time, mbPWA also provides valuable cardiac parameters such as preload, afterload, and contractility all in one go.
We create a patient-specific arterial image based on a virtually simulated arterial tree. Thus, we can determine the individual cardiovascular health of each patient within minutes, with unprecedented accuracy and conclusiveness — non-invasively, yet still directly.
Doctors and patients benefit likewise
For doctors: Unbeatably precise in the determination of values, at the same time uncomplicated and time-saving when in operation. The measurement can easily be delegated: previously with VASCASSIST 1 and 2, from 2023 on with the new appliance generation ERKAMETER 133. After a short calculation time of the easy-to-use, corresponding software program VASCVIEWER, the diagnosis is only a few clicks away with the help of the vascular avatar created by the neural network.
Patients benefit from a painless, effortless examination with certainty in minutes: No nerve-wracking wait for results.